ILXQuant Neurotechnology and Brain-Computer Interface Basket Index
Fixed-basket index of 10 companies at the frontier of understanding, treating, and augmenting the human nervous system. The basket spans closed-loop brain stimulation (NeuroPace -- responsive to seizures in milliseconds), high-frequency neuromodulation for chronic pain (Nevro), zinc-finger gene regulation for neurological disease (Sangamo), wearable neurostimulation (NeuroMetrix), non-invasive physiological monitoring (Masimo), minimally invasive medical devices (InMode), digital X-ray imaging (Nano-X), point-of-care ultrasound (Butterfly Network), precision GABA neuroscience (Praxis Precision Medicine), and CNS drug platforms (Supernus). By 2050 neurological disorders will account for approximately 40 percent of all disability-adjusted life years globally. The companies solving brain disorders today will be the Intuitive Surgicals of the 2030s. Rebalances quarterly to equal weight.
- Index identifier
- ILXNRO
- Category
- Basket
- Universe
- Fixed basket -- 10 neurotechnology and brain-computer interface companies (equal weight)
- Currency
- USD
- Inception
- 2021-06-07
- Rebalancing
- Quarterly (first Monday of March, June, September, December)
- Index fee
- 0.60% p.a.
- Reference benchmark
- Health Care SPDR (XLV)
Performance and risk
All figures below are measured over a trailing window of up to 1,260 trading days (approximately five years), not since index inception.
| Annualised return | -14.48% |
|---|---|
| Sharpe ratio | -0.32 |
| Calmar ratio | -0.19 |
| Volatility | 45.36% |
| Maximum drawdown | -76.05% |
| Return, 1 month | — |
| Return, 3 months | — |
| Return, 1 year | — |
| Return, year to date | -35.28% |
Full performance history, drawdown analysis, rolling risk metrics and portfolio breakdowns for this index are available in the ILX Quant platform.